Pharma & Bio

Latest Content

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Comment & Features

How policing the ’chain’ gangs became a lot smarter

Counterfeit products are a greater threat than ever before, warns Domino Printing Sciences' Adem Kulauzovic but options for serialisation, plus track and trace can help protect their businesses...

Analysis

Dust explosion short course at the Wolfson Centre

New hazards: COMAH 2015

The introduction of new COMAH regulations will see many smaller firms affected by the rules for the first time.